Argani Pedram, Kao Yu-Chien, Zhang Lei, Bacchi Carlos, Matoso Andres, Alaggio Rita, Epstein Jonathan I, Antonescu Cristina R
*Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD †Department of Pathology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan ‡Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY §Lab Bacchi, São Paulo, Brasil ∥University of Pittsburgh School of Medicine, Pittsburgh, PA.
Am J Surg Pathol. 2017 Dec;41(12):1702-1712. doi: 10.1097/PAS.0000000000000926.
We report 2 primary renal sarcomas demonstrating BCOR-CCNB3 gene fusions that have recently been identified in undifferentiated round cell sarcomas of bone and soft tissue. These neoplasms occurred in male children aged 11 and 12 years, and both were cystic as a result of entrapment and dilatation of native renal tubules. Both cases were composed of variably cellular bland spindle cells with fine chromatin set in myxoid stroma and separated by a branching capillary vasculature. Both neoplasms demonstrated immunoreactivity for BCOR, cyclin D1, TLE1, and SATB2 in the spindle neoplastic cells and negativity in the prominent capillary vasculature. One case was extensively cystic and had hypocellular areas that simulated cystic nephroma; this neoplasm recurred 3 years later as a solid, highly cellular spindle cell sarcoma in the abdominal cavity. The morphology and immunoprofile of these renal neoplasms was compared with a control group of other sarcomas with BCOR genetic abnormalities, including clear cell sarcoma of the kidney (CCSK), infantile undifferentiated round cell sarcomas of soft tissue/primitive myxoid mesenchymal tumor of infancy, and bone/soft tissue sarcomas with BCOR-CCNB3 gene fusion; along with primary renal synovial sarcoma. Our findings show that the renal sarcomas with BCOR-CCNB3 gene fusion overlap with CCSK. These results are in keeping with a "BCOR-alteration family" of renal and extrarenal neoplasms which includes CCSK and undifferentiated round cell sarcomas of soft tissue/primitive myxoid mesenchymal tumor of infancy (which typically harbor BCOR internal tandem duplication), and BCOR-CCNB3 sarcomas, all of which are primarily driven by BCOR overexpression and have overlapping (but not identical) clinicopathologic features.
我们报告了2例原发性肾肉瘤,其显示出BCOR-CCNB3基因融合,该融合最近在骨和软组织的未分化圆形细胞肉瘤中被发现。这些肿瘤发生在11岁和12岁的男性儿童中,由于原生肾小管的受压和扩张,两者均为囊性。两例均由细胞成分各异的淡染梭形细胞组成,染色质细腻,位于黏液样基质中,并由分支状毛细血管脉管系统分隔。两种肿瘤在梭形肿瘤细胞中均显示对BCOR、细胞周期蛋白D1、TLE1和SATB2呈免疫反应性,而在显著的毛细血管脉管系统中呈阴性。其中1例广泛囊性变,有细胞稀少区域,类似囊性肾瘤;该肿瘤3年后复发,为腹腔内实性、细胞高度丰富的梭形细胞肉瘤。将这些肾肿瘤的形态学和免疫表型与其他具有BCOR基因异常的肉瘤对照组进行比较,包括肾透明细胞肉瘤(CCSK)、婴儿软组织未分化圆形细胞肉瘤/婴儿期原始黏液样间叶肿瘤,以及具有BCOR-CCNB3基因融合的骨/软组织肉瘤;还有原发性肾滑膜肉瘤。我们的研究结果表明,具有BCOR-CCNB3基因融合的肾肉瘤与CCSK有重叠。这些结果与肾和肾外肿瘤的“BCOR改变家族”一致。该家族包括CCSK和软组织未分化圆形细胞肉瘤/婴儿期原始黏液样间叶肿瘤(通常具有BCOR内部串联重复),以及BCOR-CCNB3肉瘤,所有这些肿瘤主要由BCOR过表达驱动,并且具有重叠(但不相同)的临床病理特征。